Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay

Press/Media

Period	29 Jun 2020

Media coverage

Title	Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay
Media name/outlet	Wallstreet Online
Country/Territory	Germany
Date	29/06/20
URL	https://www.wallstreet-online.de/nachricht/12670087-multi-site-study-of-covid-19-patients-utilizing-fluidigm-mass-cytometry-technology-and-maxpar-direct-immune-profiling-assay
Persons	Adeeb Rahman